ERAP1 and cancer: In addition, several cancer models have also been shown to have attenuated ERAAP levels,79 leading to a presentation of immunogenic tumor antigens and enhanced anti-tumor immunity.80 The role of QFL T cells in different infectious disease and anti-tumor models remains to be determined but is a promising path to explore.